Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Sell
454
-400
-47% -$101K 0.01% 191
2026
Q1
$207K Sell
854
-120
-12% -$32.5K 0.01% 152
2025
Q4
$289K Hold
974
0.02% 121
2025
Q3
$275K Buy
974
+20
+2% +$5.24K 0.02% 136
2025
Q2
$281K Sell
954
-266
-22% -$68.5K 0.02% 121
2025
Q1
$303K Buy
1,220
+166
+16% +$40.6K 0.02% 113
2024
Q4
$232K Hold
1,054
0.02% 116
2024
Q3
$233K Sell
1,054
-307
-23% -$60.2K 0.02% 113
2024
Q2
$235K Hold
1,361
0.02% 115
2024
Q1
$260K Sell
1,361
-200
-13% -$36.5K 0.02% 119
2023
Q4
$255K Buy
1,561
+357
+30% +$53.9K 0.02% 110
2023
Q3
$169K Sell
1,204
-18
-1% -$2.56K 0.02% 125
2023
Q2
$164K Hold
1,222
0.01% 135
2023
Q1
$160K Buy
+1,222
New +$163K 0.02% 129

Other funds holding IBM

Avalon Trust's IBM Position: Q2 2026 in Review

Avalon Trust reduced its IBM (IBM) stake by 47% in Q2 2026, selling an estimated $101K and leaving 454 shares worth $128K. The position accounts for 0.01% of the portfolio, ranked #191.

Avalon Trust first reported a position in IBM in Q1 2023 and has held it in 14 quarters since. The position peaked at $303K in Q1 2025. 3,630 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Avalon Trust held 454 shares of IBM worth $128K as of Q2 2026.
  • Avalon Trust sold 400 IBM shares in Q2 2026, an estimated $101K.
  • IBM made up 0.01% of Avalon Trust's portfolio in Q2 2026, its #191 holding.
  • Avalon Trust first reported a position in IBM in Q1 2023 and has held it in 14 quarters since.
  • Avalon Trust's IBM position peaked at $303K in Q1 2025.
  • 3,630 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.